Phase II study of gemcitabine in ovarian cancer.
暂无分享,去创建一个
[1] M. Millward,et al. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] A Gordon,et al. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Neijt,et al. Gemcitabine in cisplatin-resistant ovarian cancer. , 1996, Seminars in oncology.
[4] P. Francis,et al. Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel. , 1996, Gynecologic oncology.
[5] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.